Notable takeaways include: Study 1: STEP 1 Trial Duration : 68 weeks Findings : Semaglutide users achieved a mean weight loss of 14.9% from baseline compared to 2.4% with placebo, resulting in an estimated treatment difference of 12.4 percentage points
Structuralfunctional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism
Wysock was concerned about making the switch, fearing that the compounded version would cause unfamiliar side effects, but it was worth it to me to try. Drugs prescribed for weight loss such as Mounjaro, Ozempic, Wegovy and Zepbound are popular, expensive, and in short supply
14-17 GLP-1RAs decrease RGC damage by preventing mitophagy in diabetic rat models and, in vitro, demonstrating the neuroprotective effects of these medications on the retina
If you inject in the thigh and then go for a run, increased blood flow to the area can worsen local reactions
Goldberg A, Graca S, Liu J, Rao V, Witchel SF, Pena A, et al
